DE3438656A1 - CAPSULE - DOSAGE FORMS - Google Patents
CAPSULE - DOSAGE FORMSInfo
- Publication number
- DE3438656A1 DE3438656A1 DE3438656A DE3438656A DE3438656A1 DE 3438656 A1 DE3438656 A1 DE 3438656A1 DE 3438656 A DE3438656 A DE 3438656A DE 3438656 A DE3438656 A DE 3438656A DE 3438656 A1 DE3438656 A1 DE 3438656A1
- Authority
- DE
- Germany
- Prior art keywords
- capsule
- body part
- units
- another
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
- B29C65/56—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using mechanical means or mechanical connections, e.g. form-fits
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
- B29C65/56—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using mechanical means or mechanical connections, e.g. form-fits
- B29C65/58—Snap connection
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
- B29C66/11—Joint cross-sections comprising a single joint-segment, i.e. one of the parts to be joined comprising a single joint-segment in the joint cross-section
- B29C66/112—Single lapped joints
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
- B29C66/11—Joint cross-sections comprising a single joint-segment, i.e. one of the parts to be joined comprising a single joint-segment in the joint cross-section
- B29C66/112—Single lapped joints
- B29C66/1122—Single lap to lap joints, i.e. overlap joints
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
- B29C66/11—Joint cross-sections comprising a single joint-segment, i.e. one of the parts to be joined comprising a single joint-segment in the joint cross-section
- B29C66/114—Single butt joints
- B29C66/1142—Single butt to butt joints
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
- B29C66/13—Single flanged joints; Fin-type joints; Single hem joints; Edge joints; Interpenetrating fingered joints; Other specific particular designs of joint cross-sections not provided for in groups B29C66/11 - B29C66/12
- B29C66/131—Single flanged joints, i.e. one of the parts to be joined being rigid and flanged in the joint area
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
- B29C66/13—Single flanged joints; Fin-type joints; Single hem joints; Edge joints; Interpenetrating fingered joints; Other specific particular designs of joint cross-sections not provided for in groups B29C66/11 - B29C66/12
- B29C66/131—Single flanged joints, i.e. one of the parts to be joined being rigid and flanged in the joint area
- B29C66/1312—Single flange to flange joints, the parts to be joined being rigid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/20—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines
- B29C66/24—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight
- B29C66/242—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/20—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines
- B29C66/24—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight
- B29C66/242—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours
- B29C66/2422—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours being circular, oval or elliptical
- B29C66/24221—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours being circular, oval or elliptical being circular
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/20—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines
- B29C66/24—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight
- B29C66/242—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours
- B29C66/2424—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours being a closed polygonal chain
- B29C66/24241—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours being a closed polygonal chain forming a triangle
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/01—General aspects dealing with the joint area or with the area to be joined
- B29C66/05—Particular design of joint configurations
- B29C66/20—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines
- B29C66/24—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight
- B29C66/242—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours
- B29C66/2424—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours being a closed polygonal chain
- B29C66/24243—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours being a closed polygonal chain forming a quadrilateral
- B29C66/24244—Particular design of joint configurations particular design of the joint lines, e.g. of the weld lines said joint lines being closed or non-straight said joint lines being closed, i.e. forming closed contours being a closed polygonal chain forming a quadrilateral forming a rectangle
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
- B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
- B29C66/53—Joining single elements to tubular articles, hollow articles or bars
- B29C66/534—Joining single elements to open ends of tubular or hollow articles or to the ends of bars
- B29C66/5346—Joining single elements to open ends of tubular or hollow articles or to the ends of bars said single elements being substantially flat
- B29C66/53461—Joining single elements to open ends of tubular or hollow articles or to the ends of bars said single elements being substantially flat joining substantially flat covers and/or substantially flat bottoms to open ends of container bodies
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
- B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
- B29C66/54—Joining several hollow-preforms, e.g. half-shells, to form hollow articles, e.g. for making balls, containers; Joining several hollow-preforms, e.g. half-cylinders, to form tubular articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
- B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
- B29C66/54—Joining several hollow-preforms, e.g. half-shells, to form hollow articles, e.g. for making balls, containers; Joining several hollow-preforms, e.g. half-cylinders, to form tubular articles
- B29C66/542—Joining several hollow-preforms, e.g. half-shells, to form hollow articles, e.g. for making balls, containers; Joining several hollow-preforms, e.g. half-cylinders, to form tubular articles joining hollow covers or hollow bottoms to open ends of container bodies
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
- B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
- B29C66/54—Joining several hollow-preforms, e.g. half-shells, to form hollow articles, e.g. for making balls, containers; Joining several hollow-preforms, e.g. half-cylinders, to form tubular articles
- B29C66/543—Joining several hollow-preforms, e.g. half-shells, to form hollow articles, e.g. for making balls, containers; Joining several hollow-preforms, e.g. half-cylinders, to form tubular articles joining more than two hollow-preforms to form said hollow articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
- B29C66/63—Internally supporting the article during joining
- B29C66/636—Internally supporting the article during joining using a support which remains in the joined object
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
- B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
- B29C66/54—Joining several hollow-preforms, e.g. half-shells, to form hollow articles, e.g. for making balls, containers; Joining several hollow-preforms, e.g. half-cylinders, to form tubular articles
- B29C66/545—Joining several hollow-preforms, e.g. half-shells, to form hollow articles, e.g. for making balls, containers; Joining several hollow-preforms, e.g. half-cylinders, to form tubular articles one hollow-preform being placed inside the other
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C66/00—General aspects of processes or apparatus for joining preformed parts
- B29C66/70—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material
- B29C66/71—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the composition of the plastics material of the parts to be joined
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Fertilizers (AREA)
- Packages (AREA)
Description
WARNER-LAMBERT COMPANY PD (314O)AWARNER-LAMBERT COMPANY PD (314O) A.
KAPSEL - DOSIERUNGSFORMENCAPSULE DOSAGE FORMS
■ ψ. ----- ■■■■■■■■ ■■■■ -■ ψ. ----- ■■■■■■■■ ■■■■ -
Die vorliegende Erfindung betrifft Dosierungsformen von hartschaligen Kapseln zur dosierten Verabreichung von festen, cremigen und flüssigen Substanzen, insbesondere Pharmazeutikas.The present invention relates to dosage forms of hard-shell capsules for the metered administration of solid, creamy and liquid substances, especially pharmaceuticals.
Die Dosierungsform der vorliegenden Erfindung besteht aus zwei oder mehreren Kapseln, die miteinander verbunden sind. Dabei können die Verbindungsstücke der Kapseln in einem Arbeitsgang mit der Kapselherstellung durch Druckformen und aus denselben Materialien wie die Kapseln hergestellt werden- Weiter können die Kapseln zwei oder mehrere nicht trennbare Abschnitte oder Sektoren in jeder Kapsel enthalten, um verschiedene Medikamente aufzunehmen. Die erfindungsgemässen Kapselarten können als eine Vielzahl von Einzeldosierungen oder als Packungen hergestellt werden. Bisher bekannte Kapseln für den pharmazeutischen Gebrauch haben nur einen einzigen Behälter zum Aufnehmen von Füllmaterial, nämlich den durch das Zusammenschieben von Kappen- und Körperteil erhaltenen Hohlraum der Kapsel.The dosage form of the present invention consists of two or more capsules that are linked together. Included the connecting pieces of the capsules can be made in one operation with the capsule production by pressure molding and from the same Materials such as the capsules can be manufactured- Further, the capsules can have two or more non-separable sections or sectors Contained in each capsule to accommodate various medications. The types of capsules according to the invention can be used as a A large number of single doses or packs can be produced. Previously known capsules for pharmaceutical use have only one container to hold filling material, namely the one created by pushing the cap and body parts together preserved cavity of the capsule.
Es ist bekannt, dass Tabletten für den Patienten die Möglichkeit bieten, die Dosierung z.B. durch Auseinanderbrechen in Stücke zu wählen. Gemäss der vorliegenden Erfindung können nun mit Druckformtechniken, vorzugsweise mittels Spritzguss, Kapseln hergestellt werden, die zwei oder mehrere Medikamente enthalten, die nicht in einer Tablette oder in bisher üblichen Kapseln kombiniert werden konnten, da ihre Aktivsubstanzen, z.B. miteinander zu unerwünschten Produkten reagieren.It is known that tablets offer the patient the option of reducing the dosage, e.g. by breaking it into pieces Select. According to the present invention, capsules can now be made using compression molding techniques, preferably by means of injection molding are manufactured that contain two or more drugs that are not in a tablet or in previously common capsules could be combined, as their active substances, e.g. react with each other to form undesirable products.
Kapseldosierungsformen gemäss der vorliegenden Erfindung können in kleinere Einheiten geteilt und geschluckt werden. Die Artikel der vorliegenden Erfindung können durch Druckformen, vorzugsweise Spritzgiessen von Stärke, hydrophilen Polymeren wie Gelatine, oderCapsule dosage forms according to the present invention can be used in smaller units are divided and swallowed. The articles of the present invention can be compression molded, preferably Injection molding of starch, hydrophilic polymers such as gelatin, or
0042Z/1000042Z / 100
Stärkederivaten, alle mit niedrigen Wassergehalten, hergestellt werden.Starch derivatives, all with low water contents.
Beim Spritzgiessen ist es wichtig, dass das zu formende, geschmolzene Material sich während des Formprozesses wie ein thermoplastisches Material verhält und anschliessend so schnell in der Form erstarrt, dass es rasch und ohne Dimensionsänderung aus der Form ausgestossen werden kann. Letzteres ist deshalb von besonderer Wichtigkeit, da von den meisten druckgeformten Artikeln hohe Formstabilität verlangt wird. Die erfindungsgemässen Artikel kann man mit höchster Genauigkeit und Dimensionsstabilität durch Druckformen, insbesondere Spritzgiessen, herstellen.In injection molding, it is important that the molten material behaves like a thermoplastic material during the molding process and then quickly turns into solidifies in the form so that it can be ejected from the form quickly and without changing dimensions. The latter is therefore of of particular importance because most compression molded articles require a high degree of dimensional stability. The articles according to the invention can be produced with the highest accuracy and dimensional stability by pressure molding, in particular injection molding.
Für die Herstellung ist erfindungsgemäss insbesondere ein hydrophiles Polymer oder eine Mischung solcher Polymere geeignet mit einem Wassergehalt von 5-25% (berechnet auf die hydrophile wasserhaltige Polymermischung) und wobei für den Fall, dass Gelatine verwendet wird, diese einen Wassergehalt von 10-20 Gew.% (berechnet auf die wasserhaltige Gelatinemischung) aufweist, und/oder Stärke oder eine Stärkemischung mit einem Wassergehalt von 5-25 Gew.%, vorzugsweise 15 - 21 Gew.% (berechnet auf die wasserhaltige Stärkemischung).According to the invention, in particular a hydrophilic polymer or a mixture of such polymers suitable with a water content of 5-25% (calculated on the hydrophilic water-containing polymer mixture) and in the event that gelatin is used, this has a water content of 10-20% by weight (calculated on the water-containing gelatin mixture), and / or starch or a starch mixture with a water content of 5-25% by weight, preferably 15-21% by weight (calculated on the water-containing starch mixture).
Die vorliegende Erfindung betrifft teilbare hartschalige Kapselformen, dadurch gekennzeichnet, dass die einzelnen Kapseleinheiten, bestehend jeweils aus einem Kappenteil und einem Körperteil, die ineinander schiebbar sind, miteinander derart verbunden sind, dass die einzelnen Kapseleinheiten leicht voneinander abgetrennt werden können.The present invention relates to divisible hard shell Capsule shapes, characterized in that the individual capsule units, each consisting of a cap part and a Body parts that can be pushed into one another are connected to one another in such a way that the individual capsule units are easily can be separated from each other.
Die vorliegende Erfindung betrifft auch hartschalige Kapselformen, bestehend aus einem Kappenteil und einem Körperteil, dadurch gekennzeichnet, dass der Körperteil mehrere Abteilungen aufweist. Diese einzelnen Kapseleinheiten können mittels einer oder mehreren Lamellen zu grösseren Einheiten verbunden sein.The present invention also relates to hard-shell capsule shapes, consisting of a cap part and a body part, characterized in that the body part has several compartments. These individual capsule units can be connected to form larger units by means of one or more lamellae.
■ h-■ h-
Die Erfindung betrifft im weiteren hartschalige Kapselpackungen, dadurch gekennzeichnet, dass die einzelnen Kapseleinheiten, jeweils bestehend aus einem Kappenteil und einem Körperteil die ineinander schiebbar sind, derart miteinander verbunden sind, dass die einzelnen Kapseleinheiten leicht voneinander abgetrennt werden können. Die verbundenen Kapseleinheiten der vorliegenden Erfindung sind vorzugsweise durch eine oder mehrere dünne Lamellen miteinander verbunden; diese verbundenen Einheiten werden vorzugsweise in einem einzigen Arbeitsgang mittels des Spritzgussverfahrens hergestellt. The invention also relates to hard-shell capsule packs, characterized in that the individual capsule units consisting of a cap part and a body part that fit into each other are slidable, are connected to one another in such a way that the individual capsule units are easily separated from one another can. The connected capsule units of the present invention are preferably connected to one another by one or more thin lamellae tied together; these connected units are preferably produced in a single operation by means of the injection molding process.
Erfindungsgemäss können die einzelnen Kapseleinheiten oder die einzelnen Abteilungen eines Körperteils z.B. mit unterschiedlichen Medikamenten gefüllt werden.According to the invention, the individual capsule units or the individual departments of a body part can be filled with different drugs, for example.
Die Kapseleinheiten können zur genauen Dosierung von festen, flüssigen und cremigen Substanzen, hauptsächlich im pharmazeutischen Bereich, verwendet werden.The capsule units can be used for precise dosing of solid, liquid and creamy substances, mainly in the pharmaceutical field.
Bevorzugte Kapseln gemäss der vorliegenden Erfindung werden aus Stärke im Spritzgussverfahren hergestellt.Preferred capsules according to the present invention are made from Starch made by injection molding.
Das Spritzgiessen von hydrophilem Material, wie z.B. wasserhaltiger Gelatine, ist in der Europäischen Patentanmeldung Pub. Nr. 92908 beschrieben und Teil der vorliegenden Erfindung.Injection molding of hydrophilic material such as water-based Gelatin, is in European Patent Pub. No. 92908 and is part of the present invention.
Hydrophile Polymere sind Polymere mit Molekularmassen von ungefähr 10 bis 10 Dalton, die in ihrer Hauptkette und/oder in Seitenketten Molekülgrupppen enthalten, die imstande sind, Wasserstoffbrücken zu bilden und/oder an solchen teilzunehmen. Die Bearbeitungstemperaturen für diese Materialien liegen im Bereich von vorzugsweise 70 - 1900C, vorzugsweise 80 - 1900C,Hydrophilic polymers are polymers with molecular masses of approximately 10 to 10 Daltons which contain molecular groups in their main chain and / or in side chains which are capable of forming and / or participating in hydrogen bonds. The processing temperatures for these materials are in the range of preferably 70-190 ° C., preferably 80-190 ° C.,
Wird als hydrophiles Polymer Gelatine verwendet, so ist diese hergestellt z.B. durch saure oder alkalische Behandlung von Kollagen, saure Behandlung von Schweinehaut oder alkalische Behandlung von Rinderhäuten. Diese Gelatinearten besitzen Molekularmassen vorzugsweise im Bereich von 10000 bis 2 χ 10 Dalton oder Molekularmassen im Bereich von 10000 bis 2 χ 10 und 10 χ 10 bis 20 χ 10 Dalton. Die verwendete Gelatine hat einen Wassergehalt von vorzugsweise 10 - 19%, besonders bevorzugt von 12 - 18 Gew. % bezogen auf die wasserhaltige Gelatinemischung.If gelatin is used as the hydrophilic polymer, it is produced e.g. by acidic or alkaline treatment of collagen, acidic treatment of pig skin or alkaline treatment of Cowhides. These types of gelatin have molecular masses preferably in the range from 10,000 to 2 × 10 Dalton or molecular masses in the range from 10,000 to 2 χ 10 and 10 χ 10 to 20 χ 10 daltons. The gelatin used has one Water content of preferably 10-19%, particularly preferably 12-18% by weight, based on the water-containing gelatin mixture.
Allen hydrophilen Polymeren, einschliesslich der Gelatine, können verschiedene Zusatzstoffe wie Plastifiziermittel, Gleitmittel, Vernetzungsmittel und Farbstoffe - wie in der Europäischen Patentanmeldung Publ. No. 92908 beschrieben - zugesetzt werden. Die hydrophilen Polymere können ausserdem bis zu 95% vorzugsweise nicht mehr als 30 Gew.% Streckmittel, wie Proteine z.B. Sonnenblumenproteine, Sojabohnenproteine, Baumwollsaatproteine; Erdnussproteine, Blutproteine, Eierproteine, Rapssaatproteine und deren acrylierte Derivate, quervernetzte Gelatine, Vinylacetate, Polysaccharide wie Cellulose, Methylcellulose, Hydroxymethylcellulose, Natriumcarboxymethylcellulose, Agar-Agar, Gummi Arabicum, Guar, Dextran, Chitin, Polymaltose, Polyfructose, Pectin, Alginate, Alginatsäure, Monosaccharride wie Glukose, Fruktose, Saccharose, Oligosaccharide, wie Laktose, Polyvinylpyrrolidon, Silikate, Bentonite, Karbonate oder Bikarbonate enthalten.All hydrophilic polymers, including gelatine, can contain various additives such as plasticizers, lubricants, Crosslinking agents and dyes - as described in European patent application Publ. 92908 described - be added. The hydrophilic polymers can also contain up to 95%, preferably not more than 30% by weight, of extenders, such as proteins e.g., sunflower proteins, soybean proteins, cottonseed proteins; Peanut proteins, blood proteins, egg proteins, Rapeseed proteins and their acrylated derivatives, cross-linked gelatine, vinyl acetates, polysaccharides such as cellulose, methyl cellulose, Hydroxymethyl cellulose, sodium carboxymethyl cellulose, agar-agar, gum arabic, guar, dextran, chitin, polymaltose, Polyfructose, pectin, alginates, alginic acid, monosaccharride like Glucose, fructose, sucrose, oligosaccharides such as lactose, Contain polyvinylpyrrolidone, silicates, bentonites, carbonates or bicarbonates.
Manche dieser Streckmittel sind ihrerseits hydrophile Polymere und können als solche zur Herstellung erfindungsgemässer Artikel verwendet werden. Solche hydrophile Polymere sind Hydroxypropylmethylcellulosephthalat (HPMCP) Polyvinylacetatphthalat (PVAP) , Celluloseacetylphthalat (CAP), Acrylate und Methacrylate, mit Phthalsäure, Bernsteinsäure oder Crotonsäure behandelte Gelatine und Schellack. Diese Polymere sind dann bevorzugt, wennSome of these extenders are themselves hydrophilic polymers and can as such for the production of articles according to the invention be used. Such hydrophilic polymers are hydroxypropyl methyl cellulose phthalate (HPMCP) polyvinyl acetate phthalate (PVAP), cellulose acetyl phthalate (CAP), acrylates and methacrylates, with Phthalic acid, succinic acid, or crotonic acid treated gelatin and shellac. These polymers are preferred when
Entero-Eigenschaften erwünscht sind. Sie enthalten vorzugsweise - 25% Wasser, besonders bevorzugt 15 - 22 Gew. % berechnet auf das wasserhaltige Polymere. Bevorzugt sind HPMCP7 PVAP und CAP, besonders PVAP und CAP. Am meisten bevorzugt ist jedoch PVAP, wobei alle im Spritzgussverfahren und mit einem Wassergehalt von 5 25%, vorzugsweise 15% - 21 Gew. % bezogen auf die Mischung, verarbeitet werden.Entero properties are desired. They preferably contain -25% water, particularly preferably 15-22% by weight, based on the water-containing polymer. HPMCP 7 PVAP and CAP, especially PVAP and CAP, are preferred. Most preferred, however, is PVAP, all of which are processed by injection molding and with a water content of 5-25%, preferably 15-21% by weight, based on the mixture.
Einige dieser Polymeren sind nicht thermoplastisch und es ist daher umso überraschender, dass sie. in Druckformverfahren verarbeitet werden können.Some of these polymers are not thermoplastic and it is therefore all the more surprising that they. processed in compression molding can be.
Die Bearbeitungstemperatur liegt im Bereich von 70 C bis 190 CThe processing temperature is in the range from 70 ° C to 190 ° C
5 2 und der Druck im Bereich von 600 bis 3000 χ 10 N/m ; wobei an sich bekannte Maschinen verwendet werden können.5 2 and the pressure in the range from 600 to 3000 χ 10 N / m; where on known machines can be used.
Bevorzugt ist eine formbare Stärkemischung aus Korn-, Weizen-, Kartoffel-, Reisund/oder Tapiokastärke. Die Stärke enthält ca. bis 100% Amylose und ca. 100 bis 0% Amylopektin, vorzugsweise 0 bis 70% Amylose und ca. 100 - 30% Amylopektin. Besonders bevorzugt ist Kartoffel- oder Maisstärke.A moldable starch mixture of corn, wheat, potato, rice and / or tapioca starch is preferred. The starch contains approx. up to 100% amylose and approx. 100 to 0% amylopectin, preferably 0 to 70% amylose and approx. 100-30% amylopectin. Particularly preferred is potato or corn starch.
Im folgenden umfassen die Begriffe "Stärke" und "Gelatine" auch Schäume, Modifikationen oder Derivate von Stärke und Gelatine und deren Kombination mit hydrophilen Polymeren, deren Eigenschaften für die Druckbzw. Spritzformung - insbesondere zur Herstellung von Kapseln-geeignet sind.In the following, the terms "starch" and "gelatin" also include Foams, modifications or derivatives of starch and gelatin and their combination with hydrophilic polymers, their properties for printing or Injection molding - especially for the production of capsules - are suitable.
Die zu verwendende Stärke hat einen Wassergehalt von 5 - 25%, vorzugsweise 15 - 21% und besonders bevorzugt 17 - 20 Gew. % bezogen auf die Stärkemischung. Sie kann ausserdem verschiedene Additive wie Plastifiziermittel, Gleitmittel, Vernetzungsmittel und/oder Farbstoffe sowie Streckmittel enthalten. Hierfür können dieselben Verbindungen wie oben für die hydrophilen Polymere beschrieben, verwendet werden. Die Bearbeitungstemperatur zum Spritzgiessen vonThe starch to be used has a water content of 5 - 25%, preferably 15-21% and particularly preferably 17-20% by weight based on the starch mixture. You can also use various additives such as plasticizers, lubricants, crosslinking agents and / or Contain dyes and extenders. For this purpose, the same compounds as described above for the hydrophilic polymers can be used, be used. The processing temperature for injection molding of
6-6-
Stärke liegt zwischen 80 und 240 C, bei einem Druck imStrength is between 80 and 240 C, with a pressure in
5 2
Bereich von 600 bis 3000 χ 10 N/m .5 2
Range from 600 to 3000 χ 10 N / m.
Die wasserhaltige, gegebenenfalls noch weitere Zusatzstoffe enthaltende Stärke wird bei diesen Temperaturen und Drucken und in bekannten Spritzgussmaschinen in an sich bekannter Weise verarbeitet.The water-containing starch, optionally containing further additives, is at these temperatures and pressures and in known injection molding machines processed in a manner known per se.
Erfindungsgemässe Artikel können auch durch Profilextrudieren, Formgiessen, Vakuumformen, thermisches Formen, Extrudieren, Giessen in Kombination mit Vakuumformen hergestellt werden. Bevorzugt ist jedoch das Spritzgiessen.Articles according to the invention can also be produced by profile extrusion, Mold casting, vacuum forming, thermal forming, extrusion, casting in combination with vacuum forming. Injection molding is preferred, however.
Die Vorteile der vorliegenden Erfindung werden durch die folgende detaillierte Beschreibung näher erläutert.The advantages of the present invention are further illustrated by the following detailed description.
Die Ausführungsformen der vorliegenden Erfindung können in 3 Gruppen eingeteilt werden.The embodiments of the present invention can be classified into 3 groups.
1) Teilbare oder trennbare Kapsel 1) Divisible or separable capsule
Die teilbare Kapsel kann ungeteilt geschluckt werden oder sie kann in Teile geteilt werden, die einzeln geschluckt werden können. Aus diesem Grund haben sowohl die verbundenen Kapseln als auch die abgetrennten Stücke eine Form, die leicht geschluckt werden kann und die zusätzlich das Anwendungsgebiet angeben kann. Der Körperteil oder der Kappenteil oder beide Teile können durch eine Lamelle verbunden sein.Eine Ausführungsform dieser Gruppe ist in Fig. 1. 2. 3 und 4 gezeigt, die eine perspektivische Ansicht einer teilbaren Kapsel, bestehend aus 2 Einheiten, jeweils bestehend ausThe divisible capsule can be swallowed whole or it can divided into parts that can be swallowed individually. For this reason, both the linked capsules and the separated pieces have a shape that can be swallowed easily and that can also indicate the area of application. Of the Body part or the cap part or both parts can be connected by a lamella. One embodiment of this group is in Fig. 1. 2. 3 and 4 are shown, which are a perspective view of a divisible capsule consisting of 2 units, each consisting of
• /It.• / It.
einem Kappenteil 2 und einem Körperteil lf darstellt. Wie aus Fig. 2, die einen Schnitt entlang der Linie 2-2 von Fig. 1 zeigt, hervorgeht, sind die beiden Körperteile 1 durch eine schwache Lamelle 5 verbunden. Die beiden Kappenteile 2 sind hingegen nicht verbunden. Fig. 3, die eine weitere Ansicht von Fig. 1 darstellt, zeigt diese Dosierungsform nach dem Füllen, oder vor dem Aufsetzen der Kappenteile 2 auf die Körperteile 1. Fig. 4 ist eine Seitenansicht von Fig. 3 nach dem Aufsetzen der Kappenteile 2 auf die Körperteile 1. Diese Ausführungsform gemäss Fig. 1-4 kann als ganze Kapsel geschluckt werden, oder aber sie kann entlang der Lamelle 5 in kleinere Einheiten geteilt werden, die ihrerseits einzeln geschluckt werden können. Die beiden Teile der teilbaren Kapsel gemäss Fig. 1-4 können mit verschiedenen oder mit demselben Medikament gefüllt werden. Im Falle des Einfüllens desselben Medikaments, wird die Dosis durch das Auseinanderbrechen halbiert. Füllt man jedoch 2 verschiedene Medikamente in die "beiden Kapselteile, so kann die erwünschte Kombination durch Abbrechen der Kapsel an der Lamelle geschluckt werden. Um den Inhalt der beiden Teile zu kennzeichnen, können die beiden Teile entweder in verschiedenen Farben hergestellt oder verschieden bedruckt werden. Die Kapselteile 1 und 2 sowie die sie verbindende Lamelle 5 können in einem Arbeitsgang durch Druckformen, vorzugsweise Spritzgiessen, hergestellt werden. Das Verbindungsstück 5 besteht aus demselben Material wie die Kapselteile 1 und 2.a cap part 2 and a body part l f represents. As can be seen from FIG. 2, which shows a section along the line 2-2 of FIG. 1, the two body parts 1 are connected by a weak lamella 5. The two cap parts 2, however, are not connected. 3, which is a further view of FIG. 1, shows this dosage form after filling, or before the cap parts 2 are placed on the body parts 1. FIG. 4 is a side view of FIG. 3 after the cap parts 2 have been placed on the body parts 1. This embodiment according to FIGS. 1-4 can be swallowed as a whole capsule, or it can be divided along the lamella 5 into smaller units, which in turn can be swallowed individually. The two parts of the divisible capsule according to FIGS. 1-4 can be filled with different or with the same medicament. In the case of filling the same drug, the break-up halves the dose. However, if two different drugs are filled into the "two capsule parts, the desired combination can be swallowed by breaking the capsule at the lamella. To identify the contents of the two parts, the two parts can either be made in different colors or have different printing." The capsule parts 1 and 2 and the lamella 5 connecting them can be produced in one operation by pressure molding, preferably injection molding.
Fig. 5 und 6 zeigen eine weitere Ausführungsform einer Kapsel mit 4 Unterteilungen. Fig. 5 ist ein Grundriss und Fig. 6 ist eine Seitenansicht von Fig 5, die 4 Kappenteile 2 und 4 Körperteile 1, die durch eine schwache Lamelle 5 miteinander verbunden sind, zeigen. Diese Kapsel kann als ganze oder die 4 Teile können einzeln eingenommen werden. Die Kapselteile bzw. Unterteilungen können mit demselben oder verschiedenden Medikamenten gefüllt werden. Weitere Ausführungsformen sind in Fig. 7 bis 12 dargestellt. Die Zahlen- Bezeichnungen sind hierbei dieselben wie in Fig. 1-6. Bei dieser Ausführungsform sind die Kappenteile 2 mit den Körperteilen 1 durch schwache Verbindungen wie in5 and 6 show a further embodiment of a capsule with 4 subdivisions. Fig. 5 is a plan view and Fig. 6 is a side view of Fig. 5 showing the 4 cap parts 2 and 4 body parts 1, which are connected to one another by a weak lamella 5 show. This capsule can be used as a whole or as the 4 parts be taken individually. The capsule parts or subdivisions can be filled with the same or different medicaments will. Further embodiments are shown in FIGS. 7 to 12. The numerical designations are the same as in Fig. 1-6. In this embodiment, the cap parts 2 are with the body parts 1 by weak connections as in
Fig. 11 und 12 gezeigt, verbunden. Die Kappenteile 2 können die Körperteile 1 überlappen. Weiter können die Kappenteile 2 von der Verbindungsstelle der Lamelle 5 eine Einbuchtung 6 aufweisen, so dass die Lamelle auch nach dem Auseinanderbrechen in Einzelteile schwer sichtbar ist.11 and 12 shown connected. The cap parts 2 can overlap the body parts 1. Next, the cap parts 2 of the Connection point of the lamella 5 have an indentation 6, so that the lamella even after breaking apart into individual parts is difficult to see.
Eine andere Ausführungsform ist in Fig. 13 und 14 dargestellt, worin die Kapsel aus 3 Teilen besteht, die einen inneren und 2 äussere Teile aufweisen, wovon jede davon wiederum aus einem Körperteil 1 und einem Kappenteil 2 besteht. In Fig. 13 und 14 sind die äusseren Teile dreieckig geformt. Andererseits können die ausseren.Teile wie in Fig. 15 und 16 eine halbkreisartige Form aufweisen. Gemäss den Ausführungsformen in Fig. 13 - 16 sind nur die Körperteile 1 mit Lamellen 5 verbunden, die Kappen sind jedoch Einzelteile.Another embodiment is shown in Figs. 13 and 14, wherein the capsule consists of 3 parts, an inner and 2 have outer parts, each of which in turn consists of a body part 1 and a cap part 2. In Figs. 13 and 14 the outer parts are triangular in shape. On the other hand, the outer parts as shown in Figs. 15 and 16 can have a semicircular shape exhibit. According to the embodiments in FIGS. 13-16, only the body parts 1 are connected to lamellae 5, but the caps are Individual parts.
2) Unterteilte Kapseln 2) Divided capsules
Diese Art von Kapseln hat 2 oder mehr Abteilungen oder Kammern für Medikamente. Sie können nicht in kleinere Einheiten zerbrochen werden, aber sie können mit 2 oder mehreren verschiedenen Medikamenten gefüllt werden ,„ die gleichzeitig geschluckt werden sollen. Es ist ein Vorteil der erfindungsgemässen Kapseln, dass die Zahl der Abteilungen bzw. Kammern nicht auf 2 beschränkt werden muss, sondern an das Anwendungsgebiet angepasst werden kann.This type of capsule has 2 or more compartments or chambers for Medication. They cannot be broken into smaller units, but they can be done with 2 or more different drugs are filled "that are to be swallowed at the same time. It is an advantage of the capsules according to the invention that the number of compartments or chambers does not have to be limited to 2, but can be adapted to the area of application.
Eine Ausführungsform dieser Gruppe ist in Fig. 17 und 18 dargestellt. Fig. 17 zeigt eine erweiterte perspektivische Ansicht einer unterteilten Kapsel mit einem Körperteil 1 und einer Kappe und mit 2 Kammern die durch eine Wand 5 getrennt sind. Jede der Abteilung bzw. Kammern enthält ein verschiedenes Medikament. Fig. 18 zeigt einen Schnitt einer in Kammern unterteilten Kapsel von Fig. 17 entlang der Linie 18 - 18 im geschlossenen Zustand, wobeiAn embodiment of this group is shown in FIGS. Fig. 17 shows an expanded perspective view a divided capsule with a body part 1 and a cap and with 2 chambers which are separated by a wall 5. Each of the Department or chambers contain a different drug. 18 shows a section of a compartmentalized capsule from FIG 17 along the line 18-18 in the closed state, wherein
■Μ-■ Μ- —*- *
man die vollständige Trennung der Medikamente der Unterteilung bzw. Kammern deutlich erkennt. Fig. 19 ist ein Grundriss einer anderen unterteilten Kapsel gemäss der vorliegenden Erfindung, bei welcher die beiden Kappenteile 2 axial an ihrem offenen Ende aneinanderstossen. Fig. 20 ist ein Schnitt von Fig. 19 entlang der Linie 20 - 20, wobei man das Aneinanderstossen der Kappen 2 an deren offenen Enden deutlich erkennt. Innerhalb dieser Kappen 2 befindet sich ein zylindrischer Körperteil 1, der durch ein eingegossenes Plättchen oder eine Trennwand 5 in 2 Kammern 11 und 12 getrennt ist und verschiedene Medikamente aufnehmen kann. Nach dem Einfüllen der Medikamente in die Kammern 11 und 12 wird jede der beiden Kappen 1 teleskopartig vom offenen Ende her über den Körper 1 geschoben, um die verschiedenen Medikamente darin einzuschliessen. Für verschiedene therapeutische Erfordernisse kann eine der Kappen 1 aus einem Material bestehen, dass im sauren Bereich des Magensekrets löslich ist. Die andere Kappe 1 und der Körperteil 2 kann aus einem darmlöslichen Material bestehen, auf diese Weise kann ein Medikament in einer Kammer im Magen und das andere, das sich in der anderen Kammer befindet, erst im Darm aufgelöst werden. Durch Variation der Materialien und/oder der Dicke der Kappen 1 und des Körperteils 2 kann man eine Kontrolle der Auflösungsgeschwindigkeit jeder der beiden Kammern 11 und 12 erreichen.one the complete separation of the drugs of the subdivision or chambers clearly recognizes. 19 is a plan view of another divided capsule according to the present invention at which the two cap parts 2 axially abut one another at their open end. Fig. 20 is a section of Fig. 19 along the line Line 20-20, where the abutting of the caps 2 at their open ends can be clearly seen. Inside these caps 2 there is a cylindrical body part 1, which is separated into two chambers 11 and 12 by a cast-in plate or a partition 5 is separate and can accommodate different drugs. After the medication has been filled into the chambers 11 and 12, each of the two caps 1 telescopically from the open end over the body 1 pushed to enclose the various drugs in it. Can be used for various therapeutic needs one of the caps 1 consist of a material that is soluble in the acidic region of the gastric secretion. The other cap 1 and the Body part 2 can consist of an enteric material, in this way a medicament in a chamber in the stomach and the the other, which is in the other chamber, can only be dissolved in the intestine. By varying the materials and / or the Thickness of the caps 1 and of the body part 2 can be used to control the rate of dissolution of each of the two chambers 11 and 12 reach.
Es ist ein weiteres Merkmal der vorliegenden Erfindung, dass Kappenteil 1 und Körperteil 2 so ineinandergeschoben werden können, dass die Oberfläche an der Ueberlappungszone J, wie in Fig. 18, 19 und 20, glatt ist.It is a further feature of the present invention that the cap part 1 and body part 2 are pushed into one another in this way that the surface at the overlap zone J, as in FIGS. 18, 19 and 20, is smooth.
3) Kapselpackunq 3) capsule pack
Eine Kapselpackung besteht aus 2 oder mehreren Kapseln, die so miteinander verbunden sind, dass sie in einzelne Kapsel-EinheitenA capsule pack consists of 2 or more capsules that are linked together so that they are divided into individual capsule units
■Jl$> · ■ Jl $> ·
abgetrennt werden können. Diese Kapselpackungen sollen nicht als ganzes geschluckt werden, sondern stellen eher eine geeignete Lagerform dar z.B. für den Fall, dass jede Einheit periodisch eingenommen werden soll.can be separated. These capsule packs are not intended to be swallowed whole, but rather represent a suitable one Storage form, for example, in the event that each unit is to be taken periodically.
Die Zahl der gesamthaft verbundenen Teile ist nicht begrenzt. Kapselpackungen können auch dazu benutzt werden, um teilbare Kapseln der Gruppe 1 und in Kammern unterteilte Kapseln der Gruppe 2 zu kombinieren. Eine Ausführungsform dieser Gruppe ist in Fig. 21 und 22 dargestellt. Fig. 21 ist ein Grundriss, der die Kapseln entlang ihrer Achse aufgereiht zeigt. Fig. 22 ist ein Schnitt von Fig. 21 entlang der Linie 22, worin man die Verbindung der Kapselkörper 1 durch die Lamellen 5, die aus demselben Material wie die Kapselkörper 1 bestehen und durch gleichzeitiges Druckformen erhalten wurden, erkennt. Die Kappenteile 2 der Kapselpackung sind nicht miteinander verbunden. Sowohl die Körperteile 1 als auch die Kappenteile 2 können mit Verschlussmechanismen versehen werden, um einen trennsicheren Verschluss zu erhalten. Eine andere Ausführungsform der Kapselpackung ist in Fig. 23 und 24 dargestellt. Fig. 23 ist ein Grundriss, der kreisförmige Anordnung der Kapseleinheiten zeigt. Fig. 24 ist ein Schnitt längs der Linie 24-24 von Fig. 23, wobei die Kapselkörper 1 durch die Verbindungsstücke 5 miteinander verbunden sind, die aus demselben Material wie die Kapselkörper 1 bestehen. Diese Verbindungsstücke 5 werden gleichzeitig mit den Kapselkörpern hergestellt. Beide Teile, d.h. die Körper 1 und die Kappen 2 können auch mit Verschlussmechanismen versehen werden.The number of parts connected in total is not limited. Capsule packs can also be used to create divisible Combine group 1 capsules and group 2 compartmentalized capsules. An embodiment of this group is shown in Fig. 21 and 22 shown. Fig. 21 is a plan view showing the capsules lined up along their axis. Fig. 22 is a section of Fig. 21 along the line 22, wherein the connection of the capsule body 1 by the lamellae 5, which are made of the same material how the capsule body 1 exist and were obtained by simultaneous pressure forming recognizes. The cap parts 2 of the Capsule packs are not connected to each other. Both the body parts 1 and the cap parts 2 can be fitted with locking mechanisms be provided in order to obtain a separation-proof closure. Another embodiment of the capsule pack is shown in FIG Figs. 23 and 24 are shown. Fig. 23 is a plan view showing circular arrangement of the capsule units. Fig. 24 is a Section along the line 24-24 of FIG. 23, the capsule bodies 1 being connected to one another by the connecting pieces 5, the consist of the same material as the capsule body 1. These connecting pieces 5 are simultaneously with the capsule bodies manufactured. Both parts, i.e. the bodies 1 and the caps 2, can also be provided with locking mechanisms.
Eine andere Ausführungsform der Kapselpackung wird in Fig. 25 und 26 dargestellt; sie dient zur Kombination 2er verschiedener Medikamente. Fig. 25 ist ein Grundriss, der die Kapseln an dem Verbindungsstück 5 hängend, zeigt. Fig. 26 ist eine Schnitt längsAnother embodiment of the capsule pack is shown in Figures 25 and 26; it is used to combine 2 different Medication. FIG. 25 is a plan view showing the capsules hanging from the connector 5. Fig. 26 is a longitudinal section
der Linie 26-26 von Fig. 25, der zeigt, wie Kapselkörper 1 und Kappen 2 gleichzeitig ohne Druckformen hergestellt werden. Die Kappenteile sind nicht miteinander verbunden. Die Kapseln sind in 2 Reihen angeordnet, so dass die 2 Medikamente in die aneinander stossenden Körperteile gefüllt werden können.the line 26-26 of Fig. 25 showing how capsule bodies 1 and Caps 2 can be produced at the same time without printing forms. The cap parts are not connected to each other. The capsules are in Arranged in 2 rows so that the 2 drugs can be filled into the body parts that are in contact with each other.
Durchdrückpackungen, sog. Blisterpackungen sind zum Verpacken von pharmazeutischen und anderen Produkten die eine hohe Dosierungsgenauigkeit erfordern, bekannt. Es ist ein weiteres Merkmal der vorliegenden Erfindung, dass man hartschalige Kapseln aus den Blisterpackungskomponenten eines Blisterschale und eines Deckblattes, die mit Hitze und Druck verschweisst wurden, herstellen kann, nachdem man die Blisterschale mit einem Medikament gefüllt hat. Erfindungsgemäss werden die Durchdrückpackungskomponenten aus wasserlöslichen und essbaren hydrophilen Polymeren hergestellt.Press-through packs, so-called blister packs, are known for the packaging of pharmaceutical and other products that require high dosing accuracy. It's another feature of the present invention that hard-shell capsules from the blister pack components of a blister shell and a Cover sheet, which were welded with heat and pressure, can be produced after the blister shell with a Has filled drug. According to the invention, the press-through pack components Made from water soluble and edible hydrophilic polymers.
Fig. 27 ist ein Grundriss einer Ausführungsform einer Kapsel-Blisterpackung, worin der Blisterbogen 10 verschiedene27 is a plan view of one embodiment of a Capsule blister pack, in which the blister sheet 10 different
Unterteilungen 11, 12, 13, 14 hat. Fig. 28 ist ein SchnittHas subdivisions 11, 12, 13, 14. Fig. 28 is a section
längs der Linie 28-28 von Fig. 27, wobei der Blisterbogen 10 mit dem Deckbogen 15 durch Druck und Hitze verschweisst wurden und die Blisterunterteilungen 11, 12, 13, 14 ... mit den Medikamenten darin versiegelt wurden. »An der Nahtstelle des Blisterbogens 10 mit dem Deckblatt 15 können Perforationen 16 zum leichteren Abtrennen der Blisterkammern 13, 14 ... angebracht werden. Fig.29, 30, 31 und 32 zeigen andere Ausführungsformen von Kapsel-Blisterpackungen, wobei dieselben Zahlenbezeichungen wie in Fig. 27 und 28 verwendet wurden. Fig. 29 und 30 zeigen Kapsel-Blisterpackungen, wobei die Blisterbogen 10 und der Deckbogen 15 symmetrische Unterteilungen 13, 14 aufweisen. Fig. 31 und 32 zeigen Kapsel-Blisterpackungen bei denen jede Einheit 11 und 12 in„weitere Kammern 17. 18, 19, 20 zur Aufnahme verschiedener Medikamente unterteilt ist.along the line 28-28 of FIG. 27, the blister sheet 10 having been welded to the cover sheet 15 by means of pressure and heat and the Blister compartments 11, 12, 13, 14 ... have been sealed with the medication in them. »At the seam of the blister sheet 10 With the cover sheet 15, perforations 16 can be made for easier separation of the blister chambers 13, 14. Fig. 29, 30, 31 and 32 show other embodiments of capsule blister packs, using the same numerical designations as in FIG Figures 27 and 28 were used. 29 and 30 show capsule blister packs, the blister sheets 10 and the Cover sheet 15 have symmetrical subdivisions 13, 14. Figs. 31 and 32 show capsule blister packs each of which Unit 11 and 12 in “further chambers 17, 18, 19, 20 for inclusion different drugs.
CopyCopy
• H-• H-
Die vorliegende Erfindung umfasst auch das Versiegeln und Verschliessen der ineinandergeschobenen Kapselteile. Dieses Versiegeln bietet einen weiteren Schutz gegen Trennung und Verfälschung des Inhalts der Kapsel, und macht die Kapsel zusätzlich feuchtigkeits- und gasdicht. Erfindungsgemässe Kapseln können für pharmazeutische Zwecke, aber auch zur exakten, quantitativen Dosierung von Farbstoffen, Chemikalien, Gewürzen, Düngemittelkombinationen für Pflanzen, Düngemittel mit Schutzsubstanzen, Samen, Kosmetika, landwirtschftliche Produkte etc. dienen.The present invention also includes the sealing and closing of the nested capsule parts. This Sealing provides further protection against separation and adulteration of the contents of the capsule, and makes the capsule additionally moisture and gas tight. Capsules according to the invention can be used for pharmaceutical purposes, but also for exact, quantitative dosing of dyes, chemicals, spices, Fertilizer combinations for plants, fertilizers with protective substances, seeds, cosmetics, agricultural products etc. serve.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54879483A | 1983-11-04 | 1983-11-04 | |
US64166484A | 1984-08-17 | 1984-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3438656A1 true DE3438656A1 (en) | 1985-05-23 |
Family
ID=27068942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3438656A Ceased DE3438656A1 (en) | 1983-11-04 | 1984-10-22 | CAPSULE - DOSAGE FORMS |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPH0673539B2 (en) |
BE (1) | BE900950A (en) |
CH (1) | CH661878A5 (en) |
DE (1) | DE3438656A1 (en) |
FR (1) | FR2554418B1 (en) |
GB (1) | GB2148841B (en) |
IT (1) | IT1178193B (en) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH669201A5 (en) * | 1986-05-05 | 1989-02-28 | Warner Lambert Co | AT ROOM TEMPERATURES FIXED AND FREE-FLOWING BASIC COMPOSITION FOR PRINTING. |
US5074426A (en) * | 1986-11-13 | 1991-12-24 | Warner-Lambert Company | Dividable capsule |
GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
GB2338896B (en) * | 1998-07-02 | 2003-05-21 | Reckitt & Colmann Prod Ltd | Chewable Capsules |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
EP1649886B1 (en) * | 1999-07-23 | 2008-04-02 | MannKind Corporation | Unit dose capsules for a dry powder inhaler |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
BR0017519B8 (en) * | 1999-07-23 | 2021-06-22 | Mannkind Corp | medicine capsule for an inhaler, and process for manufacturing a capsule comprising a powdered medicine. |
EP1204410B1 (en) | 1999-07-30 | 2012-09-12 | Capsugel Belgium NV | Multi-component pharmaceutical dosage form |
CA2391613C (en) * | 1999-11-17 | 2009-01-20 | Reckitt Benckiser (Uk) Limited | Injection-moulded water-soluble container |
US7883721B2 (en) | 2001-01-30 | 2011-02-08 | Smithkline Beecham Limited | Pharmaceutical formulation |
GB0102342D0 (en) | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
US7842308B2 (en) | 2001-01-30 | 2010-11-30 | Smithkline Beecham Limited | Pharmaceutical formulation |
DE10161441A1 (en) * | 2001-12-14 | 2003-06-18 | Triton Umweltschutz Gmbh | Metering system for delivering plant-growth modifiers, useful for supplying e.g. mycorrhiza, nutrients, stabilizers and disease-protection agents, comprises capsule having controlled release rate in soil |
US6923175B2 (en) | 2002-03-20 | 2005-08-02 | Mannkind Corporation | Inhalation apparatus |
EP1499303A4 (en) * | 2002-04-10 | 2007-07-25 | Fred H Miller | Multi-phase, multi-compartment capsular system |
TWI336260B (en) | 2002-07-25 | 2011-01-21 | Glaxo Group Ltd | Dosage form suitable for retaining drug substance |
TW200526274A (en) | 2003-07-21 | 2005-08-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
KR101273120B1 (en) | 2004-08-20 | 2013-06-13 | 맨카인드 코포레이션 | Catalysis of diketopiperazine synthesis |
DK1791542T3 (en) | 2004-08-23 | 2015-06-15 | Mannkind Corp | Diketopiperazinsalte for pharmaceutical delivery |
RU2390325C2 (en) | 2005-09-14 | 2010-05-27 | Маннкайнд Корпорейшн | Method for preparing drug based on higher affinity of active agents to crystalline microparticle surfaces |
KR20080096809A (en) | 2006-02-22 | 2008-11-03 | 맨카인드 코포레이션 | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US8454992B2 (en) | 2007-10-15 | 2013-06-04 | Capsugel Belgium Nv | Paneled capsule shells for release of pharmaceutical compositions |
JP5190515B2 (en) | 2007-10-15 | 2013-04-24 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ | Method and apparatus for producing a filled linker |
EP2537506A1 (en) | 2007-10-15 | 2012-12-26 | Capsugel Belgium NV | Linkers for multipart dosage forms for release of one or more parmaceutical compositions, and the resulting dosage forms |
EP2219624A2 (en) | 2007-11-08 | 2010-08-25 | Glaxo Group Limited | Pharmaceutical formulations |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
ES2929343T3 (en) | 2008-06-13 | 2022-11-28 | Mannkind Corp | Suction Actuated Dry Powder Inhaler for Drug Delivery |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
TWI494123B (en) | 2008-08-11 | 2015-08-01 | Mannkind Corp | Use of ultrarapid acting insulin |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
KR20200028501A (en) | 2009-06-12 | 2020-03-16 | 맨카인드 코포레이션 | Diketopiperazine microparticles with defined specific surface areas |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
GB201006216D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Compounds |
RU2571331C1 (en) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Systems and methods for dry powder drug delivery |
EP2694402B1 (en) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blister package for pharmaceutical cartridges |
JP2014518210A (en) * | 2011-06-15 | 2014-07-28 | オリエント ファーマ シーオー.,エルティーディー. | Multilayer capsule and method for producing the same |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
CA2852536A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
ITTO20120596A1 (en) * | 2012-07-06 | 2014-01-07 | Consiglio Nazionale Ricerche | PROCEDURE AND SYSTEM TO ASSEMBLE AN ORAL DOSE FORM, AND FORM OF ORAL DOSAGE |
JP6312262B2 (en) | 2012-07-12 | 2018-04-18 | マンカインド コーポレイション | Dry powder drug delivery system |
WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
EP3587404B1 (en) | 2013-03-15 | 2022-07-13 | MannKind Corporation | Microcrystalline diketopiperazine compositions, methods for preparation and use thereof |
BR112016000937A8 (en) | 2013-07-18 | 2021-06-22 | Mannkind Corp | dry powder pharmaceutical formulations, method for making a dry powder formulation and use of a dry powder pharmaceutical formulation |
JP2016530930A (en) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | Ventilation device and method |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US10653622B1 (en) | 2015-04-13 | 2020-05-19 | Pharmacoustics Technologies LLC | Individualized solid dosage products and a system and method for the globally integrated pharmaceutical manufacturing and its monitoring thereof |
JP6195280B2 (en) * | 2015-12-18 | 2017-09-13 | オリエント ファーマ シーオー.,エルティーディー. | Multilayer capsule and method for producing the same |
WO2018030956A1 (en) * | 2016-08-08 | 2018-02-15 | Structo Pte Ltd | A 3d printed article, method of use and method of manufacture |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB532041A (en) * | 1939-08-14 | 1941-01-16 | Charles Nicolle | Tubular plastic materials wrappings |
US3014614A (en) * | 1958-07-09 | 1961-12-26 | Alfred J Carroll | Disposable mold |
DE2032675B1 (en) * | 1970-07-02 | 1971-09-09 | Lohwasser, Kurt, 2000 Hamburg | cups |
GB1347189A (en) * | 1971-11-11 | 1974-02-27 | Merck Patent Gmbh | Containers for administering measured volumes of liquid pharmaceutical compositions |
GB1465383A (en) * | 1973-07-19 | 1977-02-23 | Remedia Ltd | Packaging of liquids |
US4076846A (en) * | 1974-11-22 | 1978-02-28 | Sumitomo Bakelite Company Limited | Protein-starch binary molding composition and shaped articles obtained therefor |
DE8120453U1 (en) * | 1981-07-13 | 1982-02-04 | Alsitan-Gesellschaft Wilh. E. Ronneburg & Co, 8000 München | CAPSULE FOR MEDICINAL PRODUCTS |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1211229A (en) * | 1958-12-17 | 1960-03-15 | Temporary assembly of cylindrical tubes | |
JPS434796Y1 (en) * | 1965-10-06 | 1968-02-29 | ||
FR2169491A5 (en) * | 1972-01-27 | 1973-09-07 | Henry Jean | Aseptic ice cubes - frozen and kept in covered plastic compartments |
JPS5372397A (en) * | 1976-12-06 | 1978-06-27 | Procter & Gamble | Device for taking out small quantity |
GB2050286A (en) * | 1979-06-16 | 1981-01-07 | Su Yen Wang | Suppository encapsulator |
GB2079238B (en) * | 1980-05-12 | 1984-09-05 | Glaxo Group Ltd | Plastics medicament containers |
CA1160966A (en) * | 1981-07-24 | 1984-01-24 | Michel Levesque | Waterproof plastic container |
BE896938A (en) * | 1983-06-02 | 1983-10-03 | Staar Marcel | Moulded plastic multicompartment dish for measuring food ingredient - in correct proportions for mixing food prod. e.g. for single or two-person helping |
GB2182639A (en) * | 1985-11-04 | 1987-05-20 | Scient Applied Research Sar | Drink carrier |
JPH08745U (en) * | 1993-12-28 | 1996-04-30 | 日立建機ダイナパツク株式会社 | Rolling machine with differential locking device |
-
1984
- 1984-10-16 CH CH4939/84A patent/CH661878A5/en not_active IP Right Cessation
- 1984-10-22 DE DE3438656A patent/DE3438656A1/en not_active Ceased
- 1984-10-30 FR FR8416560A patent/FR2554418B1/en not_active Expired
- 1984-10-30 BE BE6/48024A patent/BE900950A/en not_active IP Right Cessation
- 1984-10-31 GB GB08427523A patent/GB2148841B/en not_active Expired
- 1984-11-02 JP JP59230476A patent/JPH0673539B2/en not_active Expired - Lifetime
- 1984-11-02 IT IT49110/84A patent/IT1178193B/en active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB532041A (en) * | 1939-08-14 | 1941-01-16 | Charles Nicolle | Tubular plastic materials wrappings |
US3014614A (en) * | 1958-07-09 | 1961-12-26 | Alfred J Carroll | Disposable mold |
DE2032675B1 (en) * | 1970-07-02 | 1971-09-09 | Lohwasser, Kurt, 2000 Hamburg | cups |
GB1347189A (en) * | 1971-11-11 | 1974-02-27 | Merck Patent Gmbh | Containers for administering measured volumes of liquid pharmaceutical compositions |
GB1465383A (en) * | 1973-07-19 | 1977-02-23 | Remedia Ltd | Packaging of liquids |
US4076846A (en) * | 1974-11-22 | 1978-02-28 | Sumitomo Bakelite Company Limited | Protein-starch binary molding composition and shaped articles obtained therefor |
DE8120453U1 (en) * | 1981-07-13 | 1982-02-04 | Alsitan-Gesellschaft Wilh. E. Ronneburg & Co, 8000 München | CAPSULE FOR MEDICINAL PRODUCTS |
Also Published As
Publication number | Publication date |
---|---|
JPH0673539B2 (en) | 1994-09-21 |
CH661878A5 (en) | 1987-08-31 |
IT1178193B (en) | 1987-09-09 |
GB2148841B (en) | 1987-07-01 |
BE900950A (en) | 1985-04-30 |
GB8427523D0 (en) | 1984-12-05 |
IT8449110A0 (en) | 1984-11-02 |
FR2554418B1 (en) | 1989-11-24 |
FR2554418A1 (en) | 1985-05-10 |
GB2148841A (en) | 1985-06-05 |
JPS60132562A (en) | 1985-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3438656A1 (en) | CAPSULE - DOSAGE FORMS | |
DE69934831T2 (en) | MULTIPLEXES, MEDICAMENT DELIVERY SUITABLE FOR ORAL ADMINISTRATION | |
DE69822822T2 (en) | Use of a composition containing capsaicin or resiniferatoxin for the treatment of irritable bowel syndrome | |
DE3438235C2 (en) | Two-part capsules | |
DE69518006T2 (en) | METHOD FOR ENCLOSURE TABLETS IN A CAPSULE AND SOLID DOSAGE FORMS AVAILABLE BY THIS METHOD | |
DE2950977C2 (en) | ||
DE68926432T2 (en) | Solid encapsulated drug, method and device for its manufacture | |
DE69713757T2 (en) | METHOD FOR CAPSULING TABLETS IN A CAPSULE | |
DE2305280C2 (en) | Water-soluble hard-shell gelatin capsule | |
CH638535A5 (en) | Metronidazolphosphorsaeure (salts) and medicaments containing them. | |
DE19835346A1 (en) | Two-part capsule for pharmaceutical preparations for powder inhalers | |
DE60126089T2 (en) | ADMINISTRATION SYSTEM | |
DE1229248B (en) | Process for the manufacture of pharmaceuticals in solid form | |
CH633717A5 (en) | Moulded carrier for chemicals and/or pharmaceuticals | |
DE3634864A1 (en) | DELIVERY DEVICE FOR RELEASING A TEMPERATURE-RELEVANT MEASURE | |
DE3830353A1 (en) | METHOD FOR THE CONTINUOUS PRODUCTION OF SOLID PHARMACEUTICAL FORMS | |
DD269124A5 (en) | DEVICE FOR CONTROLLING RELEASE OF AN ACTIVE SUBSTANCE | |
DE69530759T2 (en) | FILM COATED TABLET CONTAINING PARACETAMOL AND DOMPERIDONE | |
DE69014092T2 (en) | Combination of a capsule and a capsule. | |
WO2016008650A1 (en) | Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders | |
DE1123437B (en) | Process for the manufacture of drug forms | |
DE2616748C2 (en) | Enteric pharmaceutical capsules | |
WO2001017377A1 (en) | Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said | |
DE3232830C2 (en) | drug | |
DE2227164A1 (en) | ANIMAL FEED AND METHOD OF MANUFACTURING THESS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
8131 | Rejection |